Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3341059 | 0.91 | CYP4F2 (0.33) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL11651264 | 0.88 | TAAR1 (0.47) | ADRA2AADRA2BADRA2CTAAR1ALDH1A1 | |
| SCHEMBL22245281 | 0.87 | TAAR1 (0.47) | MAPTTAAR1KDM4EALDH1A1GAA | |
| SCHEMBL11600164 | 0.87 | ALDH1A1 (0.40) | ADRA2BTAAR1KDM4EALDH1A1HPGD | |
| SCHEMBL16669513 | 0.87 | HTR1A (0.46) | TAAR1 | |
| SCHEMBL6561657 | 0.87 | — | — | |
| SCHEMBL233930 | 0.86 | ALDH1A1 (0.36) | CYP4F2CYP4A11ALDH1A1HPGD | |
| SCHEMBL1972956 | 0.85 | TAAR1 (0.53) | MTNR1AMTNR1BTAAR1 | |
| SCHEMBL2783361 | 0.84 | MTNR1A (0.44) | MTNR1AKDM4E | |
| Ethylene SCHEMBL27576641 | 0.84 | ALDH1A1 (0.38) | KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739670-B1 | SOL-GEL DERIVED COMPOSITIONS | ABS MAT INC (US) | 2023-10-11 | — | — | EP | claimed |
| US-10881598-B2 | Method of using personal and home care compositions containing a sol-gel derived material | ABS MATERIALS, INC. (US) | 2021-01-05 | — | — | US | claimed |
| US-10391470-B2 | Sol-gel derived compositions | ABS MATERIALS, INC. (US) | 2019-08-27 | — | — | US | claimed |
| US-20180360718-A1 | METHOD OF USING PERSONAL AND HOME CARE COMPOSITIONS CONTAINING A SOL-GEL DERIVED MATERIAL | AQUANEX TECHNOLOGIES, LLC | 2018-12-20 | — | — | US | claimed |
| US-20170028380-A1 | SOL-GEL DERIVED COMPOSITIONS | AQUANEX TECHNOLOGIES, LLC | 2017-02-02 | — | — | US | claimed |
| US-20160324746-A1 | METHOD OF USING PERSONAL AND HOME CARE COMPOSITIONS CONTAINING A SOL-GEL DERIVED MATERIAL | BRIGGS, ADAM | 2016-11-10 | — | — | US | claimed |
| US-20160316804-A1 | SOL-GEL ENCAPSULATED WATER-SOLUBLE ORGANIC LIQUIDS AND ORGANIC LIQUIDS AND METHOD OF USING SAME | AQUANEX TECHNOLOGIES, LLC | 2016-11-03 | — | — | US | claimed |
| US-20160271581-A1 | METHOD FOR REMOVING MICROCYSTINS FROM AN AQUEOUS SOLUTION USING PARTICLES HAVING A REACTIVE THIOL FUNCTIONAL GROUP | AQUANEX TECHNOLOGIES, LLC | 2016-09-22 | — | — | US | claimed |
| US-9440869-B2 | Sol-gel derived compositions | ABS MATERIALS, INC. (US) | 2016-09-13 | — | — | US | claimed |
| US-9144784-B2 | Sorbent material and method for using the same | ABS MATERIALS (US) | 2015-09-29 | — | — | US | claimed |
| US-20110132845-A1 | METHOD FOR EXTRACTING A METAL PARTICULATE FROM AN AQUEOUS SOLUTION USING A SOL-GEL DERIVED SORBENT | AQUANEX TECHNOLOGIES, LLC | 2011-06-09 | — | — | US | claimed |
| EP-1203032-A4 | COATING COMPOSITION FOR OPTICAL FIBERS | CORNING INC (US) | 2006-06-21 | — | — | EP | claimed |
| US-20040146766-A1 | Proton electrolyte membranes, methods of making proton electrolyte membranes, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION | 2004-07-29 | — | — | US | claimed |
| US-6559197-B2 | Coating for siliceous surfaces comprising a hydrolyzable silicon compound such as a trialkoxysilane, halosilane, alkoxysilane and mixtures thereof and a photoacid catalyst; shelf life | CORNING INCORPORATED | 2003-05-06 | — | — | US | claimed |
| US-20030045600-A1 | Coating for siliceous surfaces comprising a hydrolyzable silicon compound such as a trialkoxysilane, halosilane, alkoxysilane and mixtures thereof and a photoacid catalyst; shelf life | CORNING INCORPORATED | 2003-03-06 | — | — | US | claimed |
| JP-2002543039-A | — | — | 2002-12-17 | — | — | JP | claimed |
| EP-1203032-A1 | COATING COMPOSITION FOR OPTICAL FIBERS | CORNING INCORPORATED (US) | 2002-05-08 | — | — | EP | claimed |
| US-6326416-B1 | MIXTURE OF RADIATION CURABLE OLIGOMER AND ADHESION PROMOTER | CORNING INCORPORATED | 2001-12-04 | — | — | US | claimed |
| US-6316516-B1 | FOR PRODUCING PROTECTIVE COATINGS, FOR ENCAPSULATING OPTICAL FIBERS TO ENHANCE DURABILITY, NON-DELAMINATING | CORNING INCORPORATED | 2001-11-13 | — | — | US | claimed |
| WO-2000066636-A1 | COATING COMPOSITION FOR OPTICAL FIBERS | CORNING INCORPORATED (US) | 2000-11-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10881598-B2 | Method of using personal and home care compositions containing a sol-gel derived material | FPR3, FPR1, MSN | CYP4F2 4442/4885CYP4A11 3114/4885MAPT 3393/4885 |
| US-20160324746-A1 | METHOD OF USING PERSONAL AND HOME CARE COMPOSITIONS CONTAINING A SOL-GEL DERIVED MATERIAL | FPR3, FPR1, SGMS1 | CYP4F2 4392/4885CYP4A11 3026/4885MAPT 3421/4885 |
| US-20180360718-A1 | METHOD OF USING PERSONAL AND HOME CARE COMPOSITIONS CONTAINING A SOL-GEL DERIVED MATERIAL | FPR3, FPR1, SGMS1 | CYP4F2 4437/4885CYP4A11 2961/4885MAPT 3358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.